WallStreetZenWallStreetZen

NASDAQ: ICU
Seastar Medical Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ICU stock forecasts and price targets.

Forecast return on equity

Is ICU forecast to generate an efficient return?

Company
-78.28%
Industry
91.25%
Market
356.86%
ICU's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ICU forecast to generate an efficient return on assets?

Company
-57.79%
Industry
27.89%
ICU is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ICU earnings per share forecast

What is ICU's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$3.29
Avg 2 year Forecast
-$2.49

ICU revenue forecast

What is ICU's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.4M+171.62%
Avg 2 year Forecast
$3.3M+278.77%
ICU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICU revenue growth forecast

How is ICU forecast to perform vs Biotechnology companies and vs the US market?

Company
171.62%
Industry
12,155.84%
Market
1,548.38%
ICU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ICU$2.38N/AN/A
BIVI$1.14N/AN/A
RNAZ$9.49N/AN/A
PHGE$5.72$26.00+354.55%Buy
MBRX$4.29$22.00+412.82%Buy
View Top Biotech Stocks

Seastar Medical Holding Stock Forecast FAQ

What is ICU's earnings growth forecast for 2026-2027?

(NASDAQ: ICU) Seastar Medical Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 202.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,205.53%.

Seastar Medical Holding's earnings in 2026 is -$13,665,000.On average, 3 Wall Street analysts forecast ICU's earnings for 2026 to be -$11,850,854, with the lowest ICU earnings forecast at -$15,543,522, and the highest ICU earnings forecast at -$7,986,242.

In 2027, ICU is forecast to generate -$8,974,293 in earnings, with the lowest earnings forecast at -$11,657,642 and the highest earnings forecast at -$6,169,466.

If you're new to stock investing, here's how to buy Seastar Medical Holding stock.

What is ICU's revenue growth forecast for 2026-2027?

(NASDAQ: ICU) Seastar Medical Holding's forecast annual revenue growth rate of 171.62% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 12,155.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.

Seastar Medical Holding's revenue in 2026 is $881,000.On average, 3 Wall Street analysts forecast ICU's revenue for 2026 to be $8,626,078, with the lowest ICU revenue forecast at $6,138,826, and the highest ICU revenue forecast at $11,354,846.

In 2027, ICU is forecast to generate $12,028,927 in revenue, with the lowest revenue forecast at $9,210,042 and the highest revenue forecast at $15,139,795.

What is ICU's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: ICU) forecast ROA is -57.79%, which is lower than the forecast US Biotechnology industry average of 27.89%.

What is ICU's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ICU) Seastar Medical Holding's current Earnings Per Share (EPS) is -$12.50. On average, analysts forecast that ICU's EPS will be -$3.29 for 2026, with the lowest EPS forecast at -$4.31, and the highest EPS forecast at -$2.22. In 2027, ICU's EPS is forecast to hit -$2.49 (min: -$3.23, max: -$1.71).

What is ICU's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: ICU) forecast ROE is -78.28%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.